000 | 01924 a2200505 4500 | ||
---|---|---|---|
005 | 20250516215128.0 | ||
264 | 0 | _c20140725 | |
008 | 201407s 0 0 eng d | ||
022 | _a1529-2401 | ||
024 | 7 |
_a10.1523/JNEUROSCI.0247-14.2014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSzabó, Gergely G | |
245 | 0 | 0 |
_aPresynaptic calcium channel inhibition underlies CB₁ cannabinoid receptor-mediated suppression of GABA release. _h[electronic resource] |
260 |
_bThe Journal of neuroscience : the official journal of the Society for Neuroscience _cJun 2014 |
||
300 |
_a7958-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aCholecystokinin _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHippocampus _xcytology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aInhibitory Postsynaptic Potentials _xdrug effects |
650 | 0 | 4 |
_aInterneurons _xdrug effects |
650 | 0 | 4 |
_aLuminescent Proteins _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPresynaptic Terminals _xdrug effects |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xmetabolism |
650 | 0 | 4 |
_aSynapses _xdrug effects |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
650 | 0 | 4 |
_aomega-Conotoxin GVIA _xpharmacology |
700 | 1 | _aLenkey, Nora | |
700 | 1 | _aHolderith, Noemi | |
700 | 1 | _aAndrási, Tibor | |
700 | 1 | _aNusser, Zoltan | |
700 | 1 | _aHájos, Norbert | |
773 | 0 |
_tThe Journal of neuroscience : the official journal of the Society for Neuroscience _gvol. 34 _gno. 23 _gp. 7958-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1523/JNEUROSCI.0247-14.2014 _zAvailable from publisher's website |
999 |
_c23890472 _d23890472 |